An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogénesis
- Others:
- Universidad de Sevilla. Departamento de Bioquímica Médica y Biología Molecular e Inmunología
- Universidad de Sevilla. Departamento de Citología e Histología Normal y Patológica
- Asociacion Espanola Contra el Cancer (AECC)
- CIBERONC
- Consejeria de Salud, Junta de Andalucia
- European Commission (FP7HEALTH-2011-two-stage)
- Ministry of Economy and Competitiveness of Spain-FEDER (CIBERONC)
Description
The presence of the chimeric EWSR1-FLI1 oncoprotein is the main and initiating event defining Ewing sarcoma (ES). The dysregulation of epigenomic and proteomic homeostasis induced by the oncoprotein contributes to a wide variety of events involved in oncogenesis and tumor progression. Attempts at studying the effects of EWSR1-FLI1 in non-tumor cells to understand the mechanisms underlying sarcomagenesis have been unsuccessful to date, as ectopic expression of EWSR1-FLI1 blocks cell cycle progression and induces apoptosis in the tested cell lines. Therefore, it is essential to find a permissive cell type for EWSR1-FLI1 expression that allows its endogenous molecular functions to be studied. Here we have demonstrated that HeLa cell lines are permissive to EWSR1-FLI1 ectopic expression, and that our model substantially recapitulates the endogenous activity of the EWSR1-FLI1 fusion protein. This model could contribute to better understanding ES sarcomagenesis by helping to understand the molecular mechanisms induced by the EWSR1-FLI1 oncoprotein.
Additional details
- URL
- https://idus.us.es/handle//11441/147502
- URN
- urn:oai:idus.us.es:11441/147502
- Origin repository
- USE